David P. Schenkein, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 20,000 shares at $28.62 ($572K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Seasonal sale ($572k) by Director — this insider has traded AGIO in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |